Wells Fargo’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-69,934
| Closed | -$466K | – | 7227 |
|
|
2023
Q3 | $466K | Sell |
69,934
-4,424
| -6% | -$29.5K | ﹤0.01% | 3558 |
|
|
2023
Q2 | $674K | Buy |
74,358
+22,328
| +43% | +$202K | ﹤0.01% | 3539 |
|
|
2023
Q1 | $378K | Buy |
52,030
+45,030
| +643% | +$327K | ﹤0.01% | 3782 |
|
|
2022
Q4 | $51K | Sell |
7,000
-2,164
| -24% | -$15.8K | ﹤0.01% | 4543 |
|
|
2022
Q3 | $70K | Sell |
9,164
-434
| -5% | -$3.32K | ﹤0.01% | 4503 |
|
|
2022
Q2 | $66K | Buy |
9,598
+2,149
| +29% | +$14.8K | ﹤0.01% | 4623 |
|
|
2022
Q1 | $60K | Buy |
7,449
+1
| +0% | +$8 | ﹤0.01% | 5239 |
|
|
2021
Q4 | $42K | Buy |
7,448
+1
| +0% | +$6 | ﹤0.01% | 5586 |
|
|
2021
Q3 | $57K | Buy |
+7,447
| New | +$57K | ﹤0.01% | 5274 |
|
|
2021
Q1 | – | Sell |
-2,000
| Closed | -$28K | – | 7131 |
|
|
2020
Q4 | $28K | Buy |
+2,000
| New | +$28K | ﹤0.01% | 5546 |
|